AEON

0.12307.59%
JS

Jennifer Sy

Chief Accounting Officer

Ms. Jennifer Sy serves as its Chief Accounting Officer of AEON Biopharma, Inc. from 2025. Ms. Sy was Principal Financial Officer of AEON Biopharma, Inc. from April 4, 2025 to March 2026. Ms. Sy has served as Vice President, Corporate Controller at AEON Biopharma, Inc. since August 2023. Ms. Sy has held a variety of senior management positions with public and private companies in the technology, software and healthcare industries. Prior to joining the Company, Ms. Sy served as Corporate Controller at Nogin, Inc. from November 2021 to May 2023. From March 2018 to November 2021, she served as Director of Finance at Prospect Medical Holdings, Inc. From April 2014 to January 2018, she served as Controller at Eagle Business Performance Services. From August 2009 to March 2014, she served as Accounting Manager for the North America division at QAD, Inc. In these roles, she had overall responsibility for the corporate accounting and financial reporting functions. Ms. Sy began her career at Deloitte LLP as an external auditor from September 2006 to July 2009. Ms. Sy is a certified public accountant and holds a bachelor’s degree in business economics with a minor in accounting from the University of California, Los Angeles.

Positions